Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06309355
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2024-03-06
Brief Title:
Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis
Sponsor:
Hangzhou Yirui Pharmaceutical Technology Co Ltd
Organization:
Hangzhou Yirui Pharmaceutical Technology Co Ltd
Study Overview
Official Title:
A Randomized Placebo-controlled Double-blind Multi Center Phase IIa Trial Investigating the Safety Tolerability Pharmacokinetics and Efficacy of Topical Ointment YR001 in Adult Patients With Mild to Moderate Atopic Dermatitis
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is to evaluate the safety tolerability and pharmacokinetics of YR001 topical ointment in adult patients with mild to moderate atopic dermatitis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None